Get the Stockscreener App
7.18
1.85%
0.16
Cervomed Inc stock is traded at $7.18, with a volume of 87,253.
It is up +1.85% in the last 24 hours and down -17.82% over the past month.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
See More
Previous Close:
$7.02
Open:
$7.06
24h Volume:
87,253
Relative Volume:
0.77
Market Cap:
$66.43M
Revenue:
-
Net Income/Loss:
$-6.42M
P/E Ratio:
-1.2818
EPS:
-5.6013
Net Cash Flow:
$-7.45M
1W Performance:
+6.08%
1M Performance:
-17.82%
6M Performance:
-30.24%
1Y Performance:
-42.66%
1-Day Range:
$7.0049
$7.5999
1-Week Range:
$6.70
$7.5999
52-Week Range:
$1.80
$16.94
Cervomed Inc Stock (CRVO) Company Profile
Name
Cervomed Inc
Sector
Industry
Phone
(617) 744-4400
Address
20 PARK PLAZA, BOSTON
Compare CRVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
7.18 | 64.95M | 0 | -6.42M | -7.45M | -5.6013 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.66 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.42 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.43 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.29 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.45 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-25 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Dec-17-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-11-24 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Dec-11-24 | Downgrade | Morgan Stanley | Overweight → Underweight |
| Dec-10-24 | Downgrade | D. Boral Capital | Buy → Hold |
| Dec-06-24 | Initiated | ROTH MKM | Buy |
| Dec-05-24 | Initiated | H.C. Wainwright | Buy |
| Sep-18-24 | Initiated | Chardan Capital Markets | Buy |
| Jul-26-24 | Initiated | Morgan Stanley | Overweight |
| Feb-15-24 | Initiated | Canaccord Genuity | Buy |
| Nov-17-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-21-18 | Initiated | H.C. Wainwright | Buy |
View All
Cervomed Inc Stock (CRVO) Latest News
CervoMed (CRVO) Analyst Maintains Buy Rating with Price Target o - GuruFocus
CervoMed (CRVO) Gains FDA Support for Phase 3 Trial on Dementia Treatment - GuruFocus
CervoMed stock rises after FDA alignment on Phase 3 trial design - Investing.com UK
CervoMed announces FDA alignment on neflamapimod registration path - TipRanks
CervoMed announces alignment with FDA on registration path for neflamapimod in dementia with Lewy bodies - MarketScreener
CervoMed Announces Alignment With FDA On Registration Path For Neflamapimod In Dementia With Lewy Bodies - TradingView
CervoMed Gains FDA Alignment for Phase 3 Trial - TipRanks
CervoMed Inc Aligns with FDA on Phase 3 Trial for Dementia Drug - TradingView
FDA aligns with CervoMed on phase 3 trial design for DLB treatment - Investing.com
CervoMed Announces Alignment with FDA on Registration Path for Neflamapimod in Dementia with Lewy Bodies - Stock Titan
Forecasting CervoMed Inc. price range with options dataQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Will CervoMed Inc. stock outperform Nasdaq indexJuly 2025 Recap & Capital Efficient Trade Techniques - newser.com
How to integrate CervoMed Inc. into portfolio analysis toolsJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com
Tools to monitor CervoMed Inc. recovery probabilityJuly 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com
Will CervoMed Inc. (DP8) stock keep high P E multiplesQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Can technical indicators confirm CervoMed Inc.’s reversalGold Moves & Verified Momentum Stock Alerts - newser.com
Why CervoMed Inc. (DP8) stock stays undervaluedSell Signal & Technical Pattern Recognition Alerts - newser.com
What RSI levels show for CervoMed Inc. (DP8) stockMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Is CervoMed Inc. stock a defensive play in 20252025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
How CervoMed Inc. (DP8) stock gains from tech spendingJuly 2025 Pullbacks & Detailed Earnings Play Strategies - newser.com
Applying Elliott Wave Theory to CervoMed Inc.July 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com
CervoMed Inc. stock trend outlook and recovery pathJobs Report & Smart Swing Trading Alerts - newser.com
Is CervoMed Inc. stock supported by strong cash flowsMarket Weekly Review & Daily Entry Point Alerts - newser.com
Will CervoMed Inc. stock reach all time highs in 2025Wall Street Watch & Expert Verified Stock Movement Alerts - newser.com
Using flow based indicators on CervoMed Inc.Earnings Trend Report & Trade Opportunity Analysis Reports - newser.com
How CervoMed Inc. (DP8) stock reacts to fiscal policiesWeekly Investment Summary & Safe Capital Growth Tips - newser.com
Will CervoMed Inc. (DP8) stock benefit from sector leadershipVolume Spike & Technical Confirmation Trade Alerts - newser.com
Should you hold or exit CervoMed Inc. now2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com
Detecting support and resistance levels for CervoMed Inc.July 2025 Weekly Recap & Real-Time Chart Pattern Alerts - newser.com
Can CervoMed Inc. rally from current levelsJuly 2025 Macro Moves & Free Technical Pattern Based Buy Signals - newser.com
Full technical analysis of CervoMed Inc. stock2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Is CervoMed Inc. a candidate for recovery playEntry Point & Technical Pattern Alert System - newser.com
Cervomed Inc Stock (CRVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):